See what questions
a doctor would ask.
The FDA has approved Clolar (clofarabine) Intravenous Infusion for treatment of children aged 1 to 21 who have failed at least two previous cancer treatments for acute lymphocytic leukemia.
Source: summary of medical news story as reported by CBS Market Watch
About: Last resort leukemia drug receives FDA approval
Date: 29 December 2004
Source: CBS Market Watch
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City